The “EAWE: Examination of Anomalous World Experience” is a detailed semi-structured interview format whose aim is to elicit description and discussion of a person's experience of various aspects of their lived world. The instrument is grounded in the tradition of phenomenological psychopathology and aims to explore, in a qualitatively rich manner, six key dimensions of subjectivity - namely, a person's experience of: (1) Space and objects, (2) Time and events, (3) Other persons, (4) Language (whether spoken or written), (5) Atmosphere (overall sense of reality, familiarity, vitality, meaning, or relevance), and (6) Existential orientation (values, attitudes, and worldviews). The EAWE is based on and primarily directed toward experiences thought to be common in, and sometimes distinctive of, schizophrenia spectrum conditions. It can, however, also be used to investigate anomalies of world experience in other populations. After a theoretical and methodological introduction, the EAWE lists 75 specific items, often with subtypes, in its six domains, together with illustrative quotations from patients. The EAWE appears in a special issue of Psychopathology that also contains an orienting preface (where the difficulty as well as necessity of studying subjective life is acknowledged) and a brief reliability report. Also included are six ancillary or background articles, which survey phenomenologically oriented theory, research, and clinical lore relevant to the six experiential domains.

Keywords:
Schizophrenia, Lived world, Interpersonal experience, Temporality, Phenomenology of language, Derealization, Existential orientation, Qualitative/semi-structured interview, Phenomenological psychopathology, Spatial experience
1.
Gross G, Huber G, Klosterkötter J, Linz M: Bonn Scale for the Assessment of Basic Symptoms. Aachen, Shaker, 2008.
2.
Parnas J, Møller P, Kircher T, Thalbitzer J, Jansson L, Handest P, Zahavi D: EASE: Examination of Anomalous Self-Experience. Psychopathology 2005;38:236-258.
3.
Sass L, Pienkos E, Fuchs T: Other worlds: introduction to the special issue on the EAWE: Examination of Anomalous World Experience. Psychopathology 2017;50:5-9.
4.
Merleau-Ponty M: Phenomenology of Perception. London, Routledge, 2012.
5.
Sass L, Parnas J: Schizophrenia, consciousness, and the self. Schizophr Bull 2003;29:427-444.
6.
Husserl E: The Phenomenology of Internal Time Consciousness. Bloomington, Indiana University Press, 1964.
7.
James W: Principles of Psychology. Cambridge, Harvard University Press, 1890.
8.
Heidegger M: Being and Time. New York, Harper & Row, 1962.
9.
Husserl E: Cartesian Meditations. Dordrecht, Kluwer, 1950.
10.
Koehler K: First rank symptoms of schizophrenia: questions concerning clinical boundaries. Br J Psychiatry 1979;134:236-248.
11.
Conerty J, Skodlar B, Pienkos E, Byrom G, Sass L: The Examination of Anomalous World Experience in schizophrenia and other disorders: a report on reliability. Psychopathology 2017; 50:55-59.
12.
McGhie A, Chapman J: Disorders of attention and perception in early schizophrenia. Br J Med Psychol 1961;34:103-116.
13.
Cutting J: The Right Cerebral Hemisphere and Psychiatric Disorders. New York, Oxford University Press, 1990.
14.
Jaspers K: General Psychopathology. Chicago, University of Chicago Press, 1963.
15.
Cutting J: Principles of Psychopathology. Oxford, Oxford University Press, 1997.
16.
Lenzenweger M: Schizotypy and Schizophrenia: The View from Experimental Psychopathology. New York, Guilford, 2011.
17.
Chapman J: The early symptoms of schizophrenia. Br J Psychiatry 1966;112:225-251.
18.
Sechehaye M: Autobiography of a Schizophrenic Girl. New York, Penguin, 1962.
19.
Matussek P: Studies in delusional perception; in Cutting J, Shepherd M (eds): The Clinical Roots of the Schizophrenia Concept. Cambridge, Cambridge University Press, 1987, pp 89-103.
20.
Wagner P, Spiro CS: Divided Minds: Twin Sisters and Their Journey through Schizophrenia. New York, St. Martin's Press, 2008.
21.
Stanghellini G, Rosfort R: Emotions and Personhood: Exploring Fragility, Making Sense of Vulnerability. Oxford, Oxford University Press, 2013.
22.
Sass L: Madness and Modernism: Insanity in the Light of Modern Art, Literature, and Thought. New York, Basic Books, 1992; rev ed: Oxford, Oxford University Press, 2017.
23.
Jones N, Luhrmann T: Beyond the sensory: findings from an in-depth analysis of the phenomenology of “auditory hallucinations” in schizophrenia. Psychosis 2016;8:191-202.
24.
Hamilton M (ed): Fish's Schizophrenia, ed 3. Bristol, Wright, 1984.
25.
Payne R: Night's end. Schizophr Bull 2012;38:899-901.
26.
Stanghellini G: Schizophrenia and the sixth sense; in Chung M, Fulford K, Graham G (eds): Reconceiving Schizophrenia. Oxford, Oxford University Press, 2007, pp 129-150.
27.
Cutting J, Silzer H: Psychopathology of time in brain disease and schizophrenia. Behav Neurol 1990;3:197-215.
28.
Stanghellini G, Ballerini M, Presenza S, Mancini M, Raballo A, Blasi S, Cutting J: Psychopathology of lived time: abnormal time experience in persons with schizophrenia. Schizophr Bull 2016;42:45-55.
29.
Minkowski E: Lived Time. Evanston, Northwestern University Press, 1933/1970.
30.
Silverstein SM: Fragmentary phenomena scale, unpublished.
31.
Fuchs T: The temporal structure of intentionality and its disturbance in schizophrenia. Psychopathology 2007;40:229-235.
32.
Fuchs T: Temporality and psychopathology. Phenomenol Cogn Sci 2013;12:75-104.
33.
Cutting J: The Psychology of Schizophrenia. Oxford, Churchill Livingstone, 1985.
34.
Northoff G, Stanghellini G: How to link brain and experience? Spatiotemporal psychopathology of the lived body. Front Hum Neurosci 2016;10:76.
35.
Kimura B: Écrits de psychopathologie phénoménologique. Paris, Presses Universitaires de France, 1992.
36.
Conrad K: Die beginnende Schizophrenie: Versuch einer Gestaltanalyse des Wahns. Stuttgart, Thieme, 1958.
37.
Blankenburg W: Der Verlust der natürlichen Selbstverständlichkeit. Ein Beitrag zur Psychopathologie symptomarmer Schizophrenien. Stuttgart, Enke, 1971.
38.
Minkowski E: La schizophrénie. Paris, Payot, 1927.
39.
Stanghellini G, Ballerini M: What is it like to be a person with schizophrenia in the social world? A first-person perspective study on schizophrenic dissociality. Part 2: methodological issues and empirical findings. Psychopathology 2011;44:183-192.
40.
Laing RD: The Divided Self. New York, Penguin, 1965.
41.
Stanghellini G, Ballerini M: Values in persons with schizophrenia. Schizophr Bull 2007;33:131-141.
42.
Adam: Experiencing suspicious thoughts and paranoia: an account. Schizophr Bull 2011;37:656-658.
43.
Stanghellini G, Ballerini M, Lysaker P: Autism Rating Scale. J Psychopathol 2014;20:273-285.
44.
Rossi Monti M, Stanghellini G: Influencing and being influenced: the other side of “bizarre delusions.” 1. Analysis of the concept. Psychopathology 1993;26:159-164.
45.
Landis C: Varieties of Psychopathological Experience. New York, Holt, Rinehart & Winston, 1964.
46.
Cutting J: The Living, the Dead, and the Never-Alive. Hove, Forest Publishing, 2002.
47.
Reed G: The Psychology of Anomalous Experience: A Cognitive Approach. London, Hutchinson, 1972.
48.
Sass L: Delusion and double bookkeeping: in Fuchs T, Breyer T, Mundt C (eds): Karl Jaspers' Philosophy and Psychopathology. New York/Heidelberg, Springer, 2014, pp 125-147.
49.
Anonymous: Language games, paranoia, and psychosis. Schizophr Bull 2011;37:1099-1100.
50.
Bleuler E: Dementia Praecox or the Group of Schizophrenias. New York, International Universities Press, 1950.
51.
Stanghellini G: The Cratylus effect: a case study in semantic deconstruction. J Psychopathol 2016;22:80-89.
52.
Ey H: Schizophrénie: Études Cliniques et Psychopathologiques. Paris, Synthelabo, 1996.
53.
Sass L, Pienkos E: Beyond words: linguistic experience in melancholia, mania, and schizophrenia. Phenom Cogn Sci 2015;14:475-495.
54.
Binswanger L: Extravagence, perverseness, manneristic behavior, and schizophrenia; in Cutting J, Shepherd M (eds): The Clinical Roots of the Schizophrenia Concept. Cambridge, Cambridge University Press, 1987, pp 83-88.
55.
Møller P, Husby R: The initial prodrome in schizophrenia: searching for naturalistic core dimension of experience and behavior. Schizophr Bull 2000;26:217-236.
56.
Rosser R: The psychopathology of feeling and thinking in a schizophrenic. Int J Psychoanal 1979;60:177-188.
57.
Schreber DP: Memoirs of My Nervous Illness. London, Dawson, 1955.
58.
Brett C: Psychotic and mystical states of being: connections and distinctions. Philos Psychiatry Psychol 2002;9:321-341.
59.
Madeira L, Bonoldi I, Rocchetti M, et al: Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosis. Psychiatry Res 2016;238:270-276.
60.
Minkowski E: The essential disorder underlying schizophrenia and schizophrenic thought; in Cutting J, Shepherd M (eds): The Clinical Roots of the Schizophrenia Concept. Cambridge, Cambridge University Press, 1987, pp 188-212.
61.
Stanghellini G: Vulnerability to schizophrenia and lack of common sense. Schizophr Bull 2000;26:775-787.
62.
Schneider K: Clinical Psychopathology. New York, Grune & Stratton, 1959.
63.
Vodusek V, Parnas J, Tomori M, Skodlar B: The phenomenology of emotion experience in first-episode psychosis. Psychopathology 2014;47:252-260.
64.
Bouricius JK: Negative symptoms and emotions in schizophrenia. Schizophr Bull 1989;15:201-208.
65.
Henriksen M, Skodlar B, Sass L, Parnas J: Autism and perplexity: a qualitative and theoretical study of basic subjective experiences in schizophrenia. Psychopathology 2010;43:357-368.
66.
Müller-Suur H: Das Gewissheitsproblem beim schizophrenen und beim paranoischen Wahnerleben. Fortschr Neurol Psychiatr 1950;18:44-51.
67.
Kaplan B (ed): The Inner World of Mental Illness. New York, Harper & Row, 1964.
68.
Urfer A: Phenomenology and psychopathology of schizophrenia: the views of Eugene Minkowski. Philos Psychiatry Psychol 2001;8:279-289.
69.
Sass L: The Paradoxes of Delusion: Wittgenstein, Schreber, and the Schizophrenic Mind. Ithaca, Cornell University Press, 1994.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.